Table 1.
Relationship between clinicopathological features and CBFA2T2 expression
| Variables | CBFA2T2 expression | p value | |
|---|---|---|---|
| Low (n = 31) | High (35) | ||
| Gender | |||
| Male | 22 (71.4%) | 25 (70.3%) | 0.214 |
| Female | 9 (28.6%) | 10 (29.7%) | |
| Fuhrman grade | |||
| G1–2 | 14 (66.7%) | 23 (65.7%) | 0.023 |
| G3–4 | 9 (33.3%) | 3 (8.6%) | |
| Unknown | 8 (23.5%) | 9 (25.7%) | |
| pT stage | |||
| pT1–2 | 16 (51.6%) | 24 (68.6%) | 0.104 |
| pT3–4 | 8 (25.8%) | 5 (14.3%) | |
| Unknown | 7 (22.6%) | 6 (17.1%) | |
| Lymph node metastasis | |||
| Absence | 26 (83.9%) | 27 (77.1%) | 0.382 |
| Presence | 2 (6.5%) | 1 (2.9%) | |
| Unknown | 3 (9.7%) | 7 (20%) | |
| Systematic metastasis | |||
| Absence | 27 (87.1%) | 27 (77.1%) | 0.293 |
| Presence | 3 (9.7%) | 4 (11.4%) | |
| Unknown | 1 (3.2%) | 4 (11.4%) | |
| Pathological type | |||
| ccRCC | 25 (80.6%) | 25 (71.4%) | 0.158 |
| non-ccRCC | 6 (19.4%) | 10 (28.6%) | |